Akso Health Group

Stage 4 · Declining · week 16

As of Oct 22, 2026, Akso Health Group is in Stage 4, the downtrend phase, now in week 16 (since Jul 7, 2026). It closed at $1.22, 51.2% below its 52-week high and below its 200-day average, which is falling.

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. More about the company

$1.22

-3.94% today

$1.0B · Small cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is AHG early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 13w

S1 16w

S2 22w

S4 15w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 2w → S1 1w → S2 13w → S3 7w → S2 10w → S3 4w → S4 9w → S1 16w → S4 8w → S2 12w → S3 7w → S2 22w → S3 10w → S4 11w → S1 2w → S2 10w → S3 5w → S4 15w current

Total tracked: 165 weeks across 18 stage runs.

AHG among Medical Distribution6th of 11 by relative strength

All 11 →

Stocks in Medical Distribution ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	FOCLEDAP TMS S.A.	Stage 4 · wk 1	92	−12.4%
2	CAHCardinal Health, Inc.	Stage 2 · wk 1	90	+15.8%
3	HSICHenry Schein, Inc.	Stage 3 · wk 1	79	+1.1%
4	MCKMcKesson Corporation	Stage 2 · wk 7	76	+15.0%
5	CORCencora, Inc.	Stage 2 · wk 4	58	+8.4%
6	AHGAkso Health Group	Stage 4 · wk 16	36	+58.4%
7	YI111, Inc.	Stage 4 · wk 16	32	−17.3%
8	COSMCosmos Health Inc.	Stage 1 · wk 7	13	−37.8%

vs 52W High

-51.2%

$0.69 lo$2.50 hi

51.2% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 16

1w13w26w

Week 16, established downtrend

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-19.5%

200 DMA: $1.52 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.05x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↑ ⇈

Short-term trend rising strongly, and accelerating

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

+58.4%

-19.2%

-42.5%

YTD

-23.8%

-25.2%

Scan Membership

Breakout Watch

Latest: 2025-05-13

6 appearances in last 60 days. First seen: 2021-02-09.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 16 · Vol 0.05x

2026-10-21S4

Wk 16 · Vol 0.03x

2026-10-20S4

Wk 15 · Vol 0.06x

2026-10-19S4

Wk 15 · Vol 0.01x

2026-10-16S4

Wk 15 · Vol 0.03x

2026-10-15S4

Wk 15 · Vol 0.02x

2026-10-14S4

Wk 15 · Vol 0.07x

2026-10-13S4

Wk 14 · Vol 0.07x

2026-10-12S4

Wk 14 · Vol 0.19x

2026-10-09S4

Wk 14 · Vol 0.16x

2026-10-08S4

Wk 14 · Vol 0.06x

2026-10-07S4

Wk 14 · Vol 0.12x

Moving averages & range

50 DMA

$1.00

200 DMA

$1.52

52W High

$2.50

52W Low

$0.69

5D Low

$1.22

Resistance levels (recent highs)

20d High

$1.38

60d High

$1.59

120d High

$2.20

250d High

$2.50

Next resistance

+12.7%

to 20d High

ROE

-9.8%

Profit margin -135.0%

Dividend Yield

0.00%

P/B 5.8

Akso Health Group: quick answers

What stage is Akso Health Group in?

As of Oct 22, 2026, Akso Health Group (AHG) is in Stage 4, the downtrend phase. It entered Stage 4 on Jul 7, 2026 and is in week 16. What the four stages mean

Is Akso Health Group in an uptrend?

No. Akso Health Group is in a Stage 4 downtrend. It trades 19.5% below its 200-day average, which is falling.

How far is Akso Health Group from its 52-week high?

Akso Health Group closed at $1.22 on Oct 22, 2026, 51.2% below its 52-week high of $2.50. Its 52-week low is $0.69.

How has Akso Health Group performed over the past year?

As of Oct 22, 2026, Akso Health Group is down 25.2% over the past year and down 23.8% so far in 2026.

Which sector and industry is Akso Health Group in?

Akso Health Group is in the Medical Distribution industry, part of the Health Care sector.

About this companyHealth Care· Medical Distribution

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.